How has been the historical performance of Dipna Pharmachem?

Answer:The historical performance of Dipna Pharmachem shows significant fluctuations in its financial metrics over the years.

Breakdown:
Dipna Pharmachem's net sales have varied considerably, peaking at 727.56 Cr in March 2022 before declining to 124.92 Cr in March 2025. The total operating income followed a similar trend, reaching 727.56 Cr in March 2022 and dropping to 124.93 Cr by March 2025. The company's total expenditure, excluding depreciation, also decreased from 705.56 Cr in March 2022 to 121.48 Cr in March 2025. Operating profit (PBDIT) saw a decline from 22.10 Cr in March 2022 to 3.45 Cr in March 2025, while profit before tax remained relatively stable at 1.42 Cr in March 2025, consistent with the previous year. Profit after tax showed a slight decrease from 1.09 Cr in March 2024 to 0.97 Cr in March 2025. The company's total liabilities were 132.38 Cr in March 2025, slightly down from 132.90 Cr in March 2024, while total assets remained nearly unchanged at 132.38 Cr. Cash flow from operating activities has been negative, with a cash outflow of 9.00 Cr in March 2025, contributing to a net cash outflow of 13.00 Cr for the same period. Overall, the financial performance of Dipna Pharmachem reflects a challenging period with significant revenue declines and cash flow issues.